Last reviewed · How we verify
Effect of Intravitreal Bone Marrow Stem Cells on Ischemic Retinopathy (RetinaCell)
This study aims to evaluate the behavior of the intravitreal use of bone marrow derived stem cells in patients with ischemic retinopathy.
Details
| Lead sponsor | University of Sao Paulo |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 30 |
| Start date | 2011-09 |
| Completion | 2020-01 |
Conditions
- Ischemia
Interventions
- Intravitreal Bone Marrow Stem Cells
Primary outcomes
- Change in size of FAZ at 48 weeks — 1 day to 48 weeks
Countries
Brazil